Misti

Misti is an Australian MedTech company pioneering MedMisti™—a patented, hospital-grade smart inhaler designed for targeted lung delivery of advanced therapeutics. Respiratory diseases such as asthma, COPD, influenza, COVID-19, and RSV continue to pose global health challenges, with poor adherence and device misuse undermining treatment outcomes. Traditional inhalers often clog, degrade sensitive molecules, and offer only short-term relief. MedMisti™ overcomes these barriers with a breath-triggered, cloud-connected, clog-resistant design that increases deep lung delivery by 1.8x while preserving therapeutic integrity. The platform is engineered to deliver a wide range of biomolecules—including mRNA, antibodies, small molecules, and antigens—positioning it as a first-in-class solution for both chronic and infectious respiratory conditions. Built for clinical-grade reliability and digital integration, MedMisti™ is redefining respiratory care through precision delivery, patient engagement, and global scalability.